Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway.

Proceedings of the National Academy of Sciences of the United States of America
J E KravchenkoP M Chumakov

Abstract

Identification of unique features of cancer cells is important for defining specific and efficient therapeutic targets. Mutant p53 is present in nearly half of all cancer cases, forming a promising target for pharmacological reactivation. In addition to being defective for the tumor-suppressor function, mutant p53 contributes to malignancy by blocking a p53 family member p73. Here, we describe a small-molecule RETRA that activates a set of p53-regulated genes and specifically suppresses mutant p53-bearing tumor cells in vitro and in mouse xenografts. Although the effect is strictly limited to the cells expressing mutant p53, it is abrogated by inhibition with RNAi to p73. Treatment of mutant p53-expressing cancer cells with RETRA results in a substantial increase in the expression level of p73, and a release of p73 from the blocking complex with mutant p53, which produces tumor-suppressor effects similar to the functional reactivation of p53. RETRA is active against tumor cells expressing a variety of p53 mutants and does not affect normal cells. The results validate the mutant p53-p73 complex as a promising and highly specific potential target for cancer therapy.

References

Jun 22, 1999·The Journal of Biological Chemistry·T S DavisonC H Arrowsmith
Mar 5, 2002·Nature Medicine·Vladimir J N BykovGalina Selivanova
Mar 15, 2002·The Journal of Biological Chemistry·Sabrina StranoGiovanni Blandino
May 3, 2003·Cancer Cell·Meredith S IrwinWilliam G Kaelin
Apr 26, 2005·International Journal of Cancer. Journal International Du Cancer·Muriel VayssadeJean-Charles Ahomadegbe
Nov 16, 2005·Nature Medicine·Anna A SablinaPeter M Chumakov
Jul 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Wenge WangWafik S El-Deiry
Jul 25, 2006·Nature Chemical Biology·Evguenia StromAndrei V Gudkov
Oct 18, 2006·The Journal of Pathology·P J Coates
Jan 11, 2007·British Journal of Cancer·A Sullivan, X Lu
Feb 9, 2007·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Martina MüllerTobias Schilling
Mar 10, 2007·The Journal of Clinical Investigation·Helen S BellKevin M Ryan
Mar 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·A R M Ruhul AminMunna L Agarwal
Apr 13, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Mirko MarabeseMassimo Broggini

❮ Previous
Next ❯

Citations

Mar 5, 2009·Apoptosis : an International Journal on Programmed Cell Death·Chao Lu, Wafik S El-Deiry
Jul 14, 2010·Breast Cancer Research and Treatment·Christoforos G ThomasJan-Ake Gustafsson
Dec 25, 2012·Nature Cell Biology·Patricia A J Muller, Karen H Vousden
Aug 21, 2009·Nature Reviews. Cancer·Ran Brosh, Varda Rotter
Oct 27, 2010·Nature Reviews. Clinical Oncology·Chit Fang CheokDavid P Lane
Oct 10, 2009·Proceedings of the National Academy of Sciences of the United States of America·Andreas C JoergerAlan R Fersht
Jul 24, 2012·Carcinogenesis·Dawid WalerychGiannino Del Sal
Jul 3, 2010·Cold Spring Harbor Perspectives in Biology·Andrei V Gudkov, Elena A Komarova
May 14, 2010·Cold Spring Harbor Perspectives in Biology·David P LaneSonia Lain
Jun 21, 2012·Genes & Development·William A Freed-Pastor, Carol Prives
Feb 3, 2012·Molekuliarnaia biologiia·P V SpirinV S Prasolov
Jul 23, 2011·Genes & Cancer·Alessandro RufiniRichard A Knight
Mar 28, 2013·Journal of Hematology & Oncology·Manujendra N SahaHong Chang
Mar 13, 2010·Future Oncology·Jennifer WolterMeredith Irwin
Nov 20, 2013·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Javier E GirardiniGiannino Del Sal
Jan 1, 2014·Acta Biochimica Et Biophysica Sinica·Juan LiuZhaohui Feng
Apr 24, 2014·Apoptosis : an International Journal on Programmed Cell Death·Xin YuDarren R Carpizo
Oct 24, 2014·Cell Death & Disease·A KosteckaJ Zawacka-Pankau
Apr 29, 2014·FEBS Letters·Vladimir J N Bykov, Klas G Wiman
Jan 1, 2015·Progress in Biophysics and Molecular Biology·Taniya SahaGaurisankar Sa
Sep 10, 2013·Surgical Oncology Clinics of North America·Vita M Golubovskaya, William G Cance
Feb 19, 2010·Translational Oncology·Zhen Wang, Yi Sun
Sep 10, 2011·Cancer Letters·Anna-Maria MaasThorsten Stiewe
Jan 7, 2016·Frontiers in Oncology·Alejandro Parrales, Tomoo Iwakuma
Jul 27, 2010·Trends in Cell Biology·Magda M Maslon, Ted R Hupp
Mar 9, 2010·Seminars in Cancer Biology·Galina Selivanova
Mar 3, 2010·Seminars in Cancer Biology·Anwesha DeyChandra S Verma
Sep 20, 2008·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Anna VilgelmAlexander Zaika
Apr 16, 2011·The Journal of Pharmacy and Pharmacology·Soo-Hyun Kim, Crispin R Dass
Jul 2, 2011·British Journal of Pharmacology·Frank Essmann, Klaus Schulze-Osthoff
Oct 23, 2010·Journal of Internal Medicine·B Zhivotovsky, S Orrenius
Aug 6, 2013·Genes, Chromosomes & Cancer·Beatriz SoldevillaGemma Domínguez
Dec 17, 2014·Journal of Internal Medicine·J Zawacka-Pankau, G Selivanova
Aug 28, 2009·International Journal of Cancer. Journal International Du Cancer·Sarah J SeitzMartina Müller
May 11, 2010·Biochemical Pharmacology·Fang ChenWafik S El-Deiry
Mar 25, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Jürgen SonnemannJames F Beck
Sep 25, 2012·Expert Opinion on Therapeutic Targets·Varun V PrabhuWafik S El-Deiry
May 12, 2015·Trends in Cell Biology·Evrim Gurpinar, Karen H Vousden
May 30, 2015·Cell Death and Differentiation·T Soussi, K G Wiman
Feb 11, 2014·Prion·Luciana P RangelJerson L Silva
Mar 22, 2014·Cancer Cell·Patricia A J Muller, Karen H Vousden
Aug 25, 2012·Journal of Molecular Biology·Peter CanningAlex N Bullock

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.